Systematic Screening for COPD in Tabacology Consultation

University Hospital, Brest112 enrolled

Overview

COPD is a very common disease, an estimated 3 million people are affected in France. Unfortunately, this pathology is under-diagnosed. Several reasons can be mentioned: the banality of the symptoms or the several comorbidities. Screening faces a major difficulty: the realization of a spirometry. Various studies have shown the complexity of the implementation of mass screening in cities by mini-spirometry. The COPD World Health Days allow this mass screening but without visibility on the actual entry into a care pathway. The objective of this study is to assess the impact of systematic screening for COPD during a tabacology consultation

Study Type

OBSERVATIONAL

Enrollment

112

Conditions

Smoking Cessation

Eligibility

Sex: ALLMin age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects over 45 years old, followed in Tabacology unit at CHRU of BREST - No COPD patient or COPD patients not followed for more than 3 years (considered out of care) * No opposition filed Exclusion Criteria: * Patients already followed for COPD * Contraindication to spirometry * Refusal to participate

Locations (1)

Chu Brest

Brest, France

Systematic Screening for COPD in Tabacology Consultation

Overview

Conditions

Eligibility

Locations (1)

Outcomes

Primary Outcomes